Absci (ABSI) Non-Current Deferred Tax Liability (2021 - 2024)

Absci (ABSI) reported Non-Current Deferred Tax Liability of $175000.0 for Q3 2024, down 29.72% on a YoY basis from $249000.0 in Q4 2023, and little changed sequentially from $175000.0 in Q2 2024.

Absci (ABSI) Non-Current Deferred Tax Liability (2021 - 2024) Analysis & Trends

Absci (ABSI) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $175000.0 in Q3 2024.

  • For the quarter ending Q3 2024, Non-Current Deferred Tax Liability fell 29.72% year-over-year to $175000.0; the trailing twelve-month figure through Sep 2024 stood at $175000.0 (down 29.72% YoY), and the FY2023 full-year result was $186000.0, down 21.85% from the prior year.
  • Non-Current Deferred Tax Liability steadied at $175000.0 in Q3 2024, from $175000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.2 million in Q2 2021 to a low of $175000.0 in Q1 2024.
  • A 4-year average of $1.0 million and a median of $243500.0 in 2022 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability tumbled 83.52% in 2023 and fell 21.52% in 2024, its largest moves.
  • Tracing ABSI's Non-Current Deferred Tax Liability over 4 years: stood at $743000.0 in 2021, then sank by 67.97% to $238000.0 in 2022, then declined by 21.85% to $186000.0 in 2023, then dropped by 5.91% to $175000.0 in 2024.
  • Business Quant data shows ABSI's Non-Current Deferred Tax Liability at $175000.0 in Q3 2024, $175000.0 in Q2 2024, and $175000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Absci 1.23 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2024 175,000.00
Sep 30, 2024 175,000.00
Jun 30, 2024 175,000.00
Jun 30, 2024 175,000.00
Mar 31, 2024 175,000.00
Mar 31, 2024 175,000.00
Dec 31, 2023 186,000.00
Dec 31, 2023 186,000.00
Sep 30, 2023 249,000.00
Sep 30, 2023 249,000.00
Jun 30, 2023 223,000.00
Jun 30, 2023 223,000.00
Mar 31, 2023 224,000.00
Mar 31, 2023 224,000.00
Dec 31, 2022 238,000.00
Dec 31, 2022 238,000.00
Sep 30, 2022 756,000.00
Sep 30, 2022 756,000.00
Jun 30, 2022 1.09 Mn
Jun 30, 2022 1.09 Mn